Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Lanzatech New Zealand Limited patents


Recent patent applications related to Lanzatech New Zealand Limited. Lanzatech New Zealand Limited is listed as an Agent/Assignee. Note: Lanzatech New Zealand Limited may have other listings under different names/spellings. We're not affiliated with Lanzatech New Zealand Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Lanzatech New Zealand Limited-related inventors


Genetically engineered bacterium for the production of isobutylene

The invention relates to a genetically engineered bacterium having an enzyme that converts 3-hydroxyisovaleryl-coa to 3-hydroxyisovalerate and an enzyme that converts 3-hydroxyisovalerate to isobutylene. Typically, the bacterium is capable of producing isobutylene from a gaseous substrate containing co, co2, and/or h2, such as syngas or an industrial waste gas.. ... Lanzatech New Zealand Limited

Microbial fermentation for the production of terpenes

The invention provides a method for producing a terpene or a precursor thereof by microbial fermentation. Typically, the method involves culturing a recombinant bacterium in the presence of a gaseous substrate whereby the bacterium produces a terpene or a precursor thereof, such as mevalonic acid, isopentenyl pyrophosphate, dimethylallyl pyrophosphate, isoprene, geranyl pyrophosphate, farnesyl pyrophosphate, and/or farnesene. ... Lanzatech New Zealand Limited

Genetically engineered bacterium for the production of 3-hydroxybutyrate

The invention relates to a genetically engineered bacterium having an enzyme that converts acetyl-coa to acetoacetyl-coa, an enzyme that converts acetoacetyl-coa to 3-hydroxybutyryl-coa, and an enzyme that converts 3-hydroxybutyryl-coa to 3-hydroxybutyrate. The bacterium may also have enzymes to produce other downstream products, such as 3-hydroxybutyryaldehyde, and 1,3-butanediol. ... Lanzatech New Zealand Limited

System and method for controlling metabolite production in a microbial fermentation

A method is provided for controlling a metabolic profile of an anaerobic microbial fermentation culture. In particular, a metabolic profile of a fermentation process is controlled by controlling the amount of dissolved co2 provided to a culture. ... Lanzatech New Zealand Limited

Carbon capture in fermentation

The invention relates to a method for producing products by microbial fermentation. The method comprises first converting a feed stream containing methane to a gaseous substrate comprising co, of the invention include converting co h2, and co2 using a steam reforming zone and a water gas shift zone. ... Lanzatech New Zealand Limited

Crispr/cas systems for c1-fixing bacteria

The invention provides methods of genetically engineering a c1-fixing bacterium using a clustered regularly interspaced short palindromic repeats (crispr)/crispr-associated (cas) (crispr/cas) system. Preferably, the cas protein is under the control of an inducible promoter.. ... Lanzatech New Zealand Limited

Product management in biological conversion processes

Improvements in biological conversion processes and associated apparatuses are disclosed for the generation of useful end products such as ethanol, through metabolic pathways of c1-fixing bacteria that utilize, as a nutrient, a c1-carbon source from a c1-containing substrate such as an industrial waste gas. Particular aspects of the disclosure relate to the downstream recovery of ethanol and/or isopropanol from bleed and permeate streams and more particularly to performing such recovery with improved efficiency that can advantageously reduce capital (e.g., equipment) and/or operating (e.g., utility) costs.. ... Lanzatech New Zealand Limited

Low pressure separator having an internal divider and uses therefor

Improvements in biological conversion processes and associated apparatuses are disclosed for the generation of useful end products such as ethanol, through metabolic pathways of c1-fixing bacteria that utilize, as a nutrient, a c1-carbon source from a c1-containing substrate such as an industrial waste gas. Particular aspects of the disclosure relate to the downstream recovery of ethanol and/or isopropanol from bleed and permeate streams and more particularly to performing such recovery with improved efficiency that can advantageously reduce capital (e.g., equipment) and/or operating (e.g., utility) costs. ... Lanzatech New Zealand Limited

Integrated fermentation and electrolysis process

The invention provides schemes for the integration of a fermentation process, with an electrolysis process, and a c1-generating industrial process. In particular, the invention provides process for utilizing electrolysis products, for example h2 and/or o2, to improve the process efficiency of at least one of the fermentation process or the c1-generating industrial process. ... Lanzatech New Zealand Limited

Microorganism with modified hydrogenase activity

The invention provides genetically engineered microorganisms with modified hydrogenase activity and methods related thereto. Typically, the microorganisms are c1-fixing microorganisms with one or more disruptive mutations in a hydrogenase enzyme or a hydrogenase accessory enzyme. ... Lanzatech New Zealand Limited

Control of bioreactor processes

Processes, as well as associated systems and computer program (software) products, are disclosed for the biological conversion of co into desired end products such as ethanol. The control methodologies used for these processes can advantageously result in a reduced time required for a batch operation or other initial operating period, prior to achieving a continuous operation, which may be demarcated either by the addition of fresh culture medium at a defined flow rate or by another process initiation target. ... Lanzatech New Zealand Limited

Arginine supplementation to improve efficiency in gas fermenting acetogens

The invention provides methods for improving efficiency of fermentation by arginine supplementation, and genetically modified bacterium for use therefor. More particularly the invention provides methods for (i) increasing the production atp intensive products with arginine supplementation, (ii) increasing utilization of arginine by a c1-fixing bacterium; and (iii) providing c1-fixing bacterium with optimized arginine de-aminase pathways.. ... Lanzatech New Zealand Limited

Genetically engineered bacterium comprising energy-generating fermentation pathway

The invention relates to a genetically engineered bacterium comprising an energy-generating fermentation pathway and methods related thereto. In particular, the invention provides a bacterium comprising a phosphate butyryltransferase (ptb) and a butyrate kinase (buk) (ptb-buk) that act on non-native substrates to produce a wide variety of products and intermediates. ... Lanzatech New Zealand Limited

Vitamin prototrophy as a selectable marker

One or more genes in a biosynthesis pathway for a vitamin or other essential nutrient which is needed for the survival of a microorganism can be used as an effective selective marker to identify cells transformed with an exogenous nucleic acid. The microorganism does not naturally contain or express the one or more gene. ... Lanzatech New Zealand Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Lanzatech New Zealand Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Lanzatech New Zealand Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###